Jackie Grant
Ariel InvestmentsJackie Grant is a Vice President, Research Analyst and Client Portfolio Manager at Ariel Investments, a global asset management firm. She has over 12 years of life science experience, including translational research, business development and investing. Previously, she was principal at Abingworth (now part of Carlyle), a transatlantic life sciences venture capital firm based in Boston. Her role at Abingworth included serving on the boards of Atsena Therapeutics and Nido Biosciences and as an observer on the Anjarium and Glycomine boards.
Prior to that, Jackie was a Senior Associate at SV Health Investors. She was formerly in the Business Development Group at Genentech with primary responsibility for partnering activities in neuroscience. Her transactions span a broad spectrum of deal structures and therapeutic areas, including technology and platform in-licenses and research collaborations. Jackie has a PhD in Neuroscience from Stanford School of Medicine and an MBA from Stanford Graduate School of Business.
MORE BOARD MEMBERS
-
Sharon McNally
Chief Executive Officer, Camp Harbor View
-
Sonja Kelly
Kelly Family Foundation
-
Bryan Rafanelli
Rafanelli Events
-
Fred Seigel
Beacon Capital Partners
-
Bill O’Malley
CHV Board Chairman, IR+M
-
Orlando C. Watkins
The Boston Foundation
-
Davis Weinstock
Mercury Clark & Weinstock
-
Joseph R. Nolan, Jr.
Eversource Energy
-
Kanna Kunchala
City Year
-
Anthony Tivnan
Magellan Jets
